BioLineRx Ltd. (BLRX) - Latest Market Data

Price & Market Data

Price: $3.06

Daily Change: +$0.20 / 6.54%

Daily Range: $2.78 - $3.06

Market Cap: $13,768,197

Daily Volume: 55,391

Performance Metrics

1 Week: -1.32%

1 Month: 26.16%

3 Months: 6.03%

6 Months: -6.56%

1 Year: -17.40%

YTD: 8.33%

About BioLineRx Ltd. (BLRX)

Analyze the market position of BioLineRx Ltd. (BLRX). With a current price of 3.06, the stock exhibits a +$0.20 / 6.54% daily trend. A market capitalization of 13,768,197 indicates its scale. Discover its performance over 1-month (26.16%) and 3-month (6.03%) periods.

Company Details

Employees: 24

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Israel

Details

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Selected stocks

Sequans Communications S.A. (SQNS)

SunPower Inc. (SPWR)

17 Education & Technology Group Inc. (YQ)

Accendra Health, Inc. (ACH)